MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1

Journal of Cellular Physiology

Volumn 229, Issue 6, 2014, Pages 772-782

  Fu, Yuxuan ^a   Liu, Xianghua ^a   Zhou, Ningtian ^b   Du, Lijian ^a   Sun, Yu ^c   Zhang, Xiang ^a   Ge, Yingbin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MICRORNA 200B; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 84894234956     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24497     Document Type: Article

References (45)

1. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
2. Bellone G, Gramigni C, Vizio B, Mauri FA, Prati A, Solerio D, Dughera L, Ruffini E, Gasparri G, Camandona M. 2010. Abnormal expression of Endoglin and its receptor complex (TGF-beta1 and TGF-beta receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa. Int J Oncol 37:1153-1165.
3. Bhagat TD, Zhou L, Sokol L, Kessel R, Caceres G, Gundabolu K, Tamari R, Gordon S, Mantzaris I, Jodlowski T, Yu Y, Jing X, Polineni R, Bhatia K, Pellagatti A, Boultwood J, Kambhampati S, Steidl U, Stein C, Ju W, Liu G, Kenny P, List A, Bitzer M, Verma A. 2013. miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling. Blood 121:2875-2881.
4. Bierie B, Moses H. 2006. TGF-β and cancer. Cytokine Growth Factor Rev 17:29-40.
5. Chardin P. 2006. Function and regulation of Rnd proteins. Nat Rev Mol Cell Biol 7:54-62.
6. Chen Y, Xiao Y, Ge W, Zhou K, Wen J, Yan W, Wang Y, Wang B, Qu C, Wu J, et al. 2013. miR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis 4:e541.
7. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. 2007. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128:281-294.
8. Cui X, Witalison EE, Chumanevich AP, Chumanevich AA, Poudyal D, Subramanian V, Schetter AJ, Harris CC, Thompson PR, Hofseth LJ. 2013. The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest. PLoS ONE 8:e53791.
9. Deng M, Tang H, Zhou Y, Zhou M, Xiong W, Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al. 2011. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma. J Cell Sci 124:2997-3005.
10. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, et al. 2010. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12:390-399.
11. Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A. 1995. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4:549-554.
12. Geng Y, Weinberg RA. 1993. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 90:10315-10319.
13. Gong J, Ammanamanchi S, Ko TC, Brattain MG. 2003. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Cancer Res 63:3340-3346.
14. Grise F, Sena S, Bidaud-Meynard A, Baud J, Hiriart J-B, Makki K, Dugot-Senant N, Staedel C, Bioulac-Sage P, Zucman-Rossi J, et al. 2012. Rnd3/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology 55:1766-1775.
15. Guasch RM, Scambler P, Jones GE, Ridley AJ. 1998. RhoE regulates actin cytoskeleton organization and cell migration. Mol Cell Biol 18:4761-4771.
16. Gulubova M, Manolova I, Ananiev J, Julianov A, Yovchev Y, Peeva K. 2010. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer. Int J Colorectal Dis 25:591-599.
17. Hengst L, Reed SI. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864.
18. Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC, Wu CH, Ho YS, Wei PL, Chang YJ. 2012. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. Ann Surg Oncol. 2012 Aug 7 [Epub ahead of print].
19. Klein RM, Aplin AE. 2009. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions. Cancer Res 69:2224-2233.
20. Kong DJ, Li YW, Wang ZW, Banerjee S, Ahmad A, Kim HRC, Sarkar FH. 2009. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 27:1712-1721.
21. Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, Arends JW, Stockbrugger RW, Blijham GH. 1994. Proliferating cell nuclear antigen (PCNA): A new marker to study human colonic cell proliferation. Gut 35:530-535.
22. Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H. 2012. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 19:S656-S664.
23. Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG. 2012. TGF-beta signalling in colon carcinogenesis. Cancer Lett 314:1-7.
24. MacKay SL, Auffenberg T, Tannahill CL, Ksontini R, Josephs MD, Nowak M, Moldawer LL, Copeland EM III. 1998. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype. Ann Surg 227:781-789.
25. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67:753-791.
26. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S. 2008. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14:2690-2695.
27. Ono H, Imoto I, Kozaki K, Tsuda H, Matsui T, Kurasawa Y, Muramatsu T, Sugihara K, Inazawa J. 2012. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 31:4923-4934.
28. Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A, Goodall GJ. 2013. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia (New York, N.Y.) 15:180-191.
29. Poch E, Minambres R, Mocholi E, Ivorra C, Perez-Arago A, Guerri C, Perez-Roger I, Guasch RM. 2007. RhoE interferes with Rb inactivation and regulates the proliferation and survival of the U87 human glioblastoma cell line. Exp Cell Res 313:719-731.
30. Riou P, Villalonga P, Ridley AJ. 2010. Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression. BioEssays 32:986-992.
31. Roberts AB. 1998. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119.
32. Roberts AB, Wakefield LM. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100:8621-8623.
33. Robson H, Anderson E, James RD, Schofield PF. 1996. Transforming growth factor beta 1 expression in human colorectal tumours: An independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 74:753-758.
34. Schroy P, Rifkin J, Coffey RJ, Winawer S, Friedman E. 1990. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res 50:261-265.
35. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 14:3683-3694.
36. Sun Y, Luo D, Liao DJ. 2012. CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells. J Carcinog 11:12.
37. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. 2006. Colorectal cancer: Genetics of development and metastasis. J Gastroenterol 41:185-192.
38. Tryndyak VP, Beland FA, Pogribny IP. 2010. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 126:2575-2583.
39. Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S, Sahin O. 2010. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29:4297-4306.
40. Villalonga P, Guasch RM, Riento K, Ridley AJ. 2004. RhoE inhibits cell cycle progression and Ras-induced transformation. Mol Cell Biol 24:7829-7840.
41. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. 2005. Colorectal cancer. Lancet 365:153-165.
42. Xia W, Li J, Chen L, Huang B, Li S, Yang G, Ding H, Wang F, Liu N, Zhao Q, et al. 2010. MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol Cell Biochem 344:261-266.
43. Xu Y, Pasche B. 2007. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 16: Spec No 1, R14-R20.
44. Zhai H, Song B, Xu X, Zhu W, Ju J. 2013. Inhibition of autophagy and tumor growth in colon cancer by miR-502. Oncogene 32:1570-1579.
45. Zhou H, Wang K, Hu Z, Wen J. 2013. TGF-beta1 alters microRNA profile in human gastric cancer cells. Chin J Cancer Res 25:102-111.